Hiroaki Ikesue

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 11

Top Venues

Journal of pharmaceutical health care and sciences

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Journal of clinical pharmacy and therapeutics

Cancer chemotherapy and pharmacology

Kyushu University (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Kyushu University

Japan

PHD :: Faculty of Pharmaceutical Sciences

Kyusyu University

Japan

BSC :: Faculty of Pharmaceutical Sciences

Publications

Kenta Yamaoka, Nobuyuki Katakami, Nobuhiro Hiramoto, Masaki Hirabatake, Hiroaki Ikesue, Tohru Hashida, Tadashi Shimizu, Takayuki Ishikawa, Nobuyuki Muroi
Safety and blood levels of daratumumab after switching from intravenous to subcutaneous administration in patients with multiple myeloma. Investigational new drugs (2023)
Hiroaki Ikesue, Kenta Yamaoka, Ayako Matsumoto, Masaki Hirabatake, Nobuyuki Muroi, Toshinari Yamasaki, Mutsushi Kawakita, Tohru Hashida
Risk factors of proteinuria and potentially protective effect of renin-angiotensin system inhibitors in patients with renal cell carcinoma receiving axitinib. Cancer chemotherapy and pharmacology 89 (6) (2022)
Hiroaki Ikesue, Moe Mouri, Hideaki Tomita, Masaki Hirabatake, Mai Ikemura, Nobuyuki Muroi, Shinsuke Yamamoto, Toshihiko Takenobu, Keisuke Tomii, Mutsushi Kawakita, Hironori Katoh, Takayuki Ishikawa, Hisateru Yasui, Tohru Hashida
Associated characteristics and treatment outcomes of medication-related osteonecrosis of the jaw in patients receiving denosumab or zoledronic acid for bone metastases. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 29 (8) (2021)
Hiroaki Ikesue, Kohei Doi, Mayu Morimoto, Masaki Hirabatake, Nobuyuki Muroi, Shinsuke Yamamoto, Toshihiko Takenobu, Tohru Hashida
Risk evaluation of denosumab and zoledronic acid for medication-related osteonecrosis of the jaw in patients with bone metastases: a propensity score-matched analysis. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2021)
Hiroaki Ikesue, Kohei Doi, Mayu Morimoto, Masaki Hirabatake, Nobuyuki Muroi, Shinsuke Yamamoto, Toshihiko Takenobu, Tohru Hashida
Switching from zoledronic acid to denosumab increases the risk for developing medication-related osteonecrosis of the jaw in patients with bone metastases. Cancer chemotherapy and pharmacology 87 (6) (2021)
Shiori Hasegawa, Hiroaki Ikesue, Satoshi Nakao, Kazuyo Shimada, Ririka Mukai, Mizuki Tanaka, Kiyoka Matsumoto, Misaki Inoue, Riko Satake, Yu Yoshida, Fumiya Goto, Tohru Hashida, Mitsuhiro Nakamura
Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report database. Pharmacoepidemiology and drug safety 29 (10) (2020)
Hiroaki Ikesue, Kaori Kusuda, Yukari Satsuma, Fuki Nishiwaki, Rieko Miura, Yoshio Masuda, Masaki Hirabatake, Nobuyuki Muroi, Daichi Fujimoto, Takeshi Morimoto, Keisuke Tomii, Tohru Hashida
Evaluation of the usefulness of protocol-based pharmacist-facilitated laboratory monitoring to ensure the safety of immune checkpoint inhibitors in patients with lung cancer. Journal of clinical pharmacy and therapeutics 45 (6) (2020)
Saki Yoshida, Ayumi Fujimoto, Keizo Fukushima, Motozumi Ando, Kei Irie, Tatsuya Hirano, Moena Miyasaka, Yoshimitsu Shimomura, Takayuki Ishikawa, Hiroaki Ikesue, Nobuyuki Muroi, Tohru Hashida, Nobuyuki Sugioka
Population pharmacokinetics of tacrolimus in umbilical cord blood transplant patients focusing on the variation in red blood cell counts. Journal of clinical pharmacy and therapeutics 46 (1) (2020)
Hiroaki Ikesue, Tohru Nagano, Tohru Hashida
A Case of Acute Kidney Injury Associated With Dabrafenib and Trametinib Treatment for Metastatic Melanoma. The Annals of pharmacotherapy 52 (10) (2018)
Tomoki Takase, Hiroaki Ikesue, Makiko Tohi, Hiroshi Ueta, Hiroyuki Mima, Tadaaki Koyama, Tohru Hashida
Interaction between warfarin and short-term intravenous amiodarone in intensive care unit patients after cardiac surgery. Journal of pharmaceutical health care and sciences 4 (2018)
Haruna Yamamoto, Hiroaki Ikesue, Mai Ikemura, Rieko Miura, Kazumi Fujita, Hobyung Chung, Yoshiki Suginoshita, Tetsuro Inokuma, Tohru Hashida
Evaluation of pharmaceutical intervention in direct-acting antiviral agents for hepatitis C virus infected patients in an ambulatory setting: a retrospective analysis. Journal of pharmaceutical health care and sciences 4 (2018)

Hiroaki Ikesue.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hiroaki Ikesue